ArticleBlood advances2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Ann T Farrell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it